Patent · US Active

Glucagon-like-peptide-2 (GLP-2) analogues

US10253080B2 · kind B2 · utility

1Cited by

28References

35Claims

0Family size

Assignee

Zealand Pharma A/S · DK

Inventors

Rasmus JUST · Copenhagen, DK
Kirsten Lindegaard Bovbjerg · Hørsholm, DK
Ditte Riber · Copenhagen, DK
Wayne Shaun Russell · Katrineholm, SE

Key dates

Filing date	Apr 11, 2018
Grant date	Apr 9, 2019
Priority date	—
Expiry date	Apr 11, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

GLP-2 analogs are disclosed which comprise one of more substitutions as compared to h[Gly2]GLP-2 and which may have the property of an altered GLP-1 activity, and their medical use. The analogs are particularly useful for the prophylaxis treatment or ameliorating of the gastro-intestinal associated side effects of diabetes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.